Mega Lifesciences PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Millions THB. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	14,147	15,344	15,681	15,686	14,136
Other Revenue	47.34	41.09	34.41	40.64	36.67
Revenue	14,195	15,385	15,716	15,727	14,172
Revenue Growth (YoY)	-7.74%	-2.10%	-0.07%	10.97%	12.36%
Cost of Revenue	6,764	7,590	8,586	8,647	8,225
Gross Profit	7,431	7,796	7,130	7,080	5,947
Selling, General & Admin	4,481	4,385	4,191	4,359	3,769
Operating Expenses	4,481	4,385	4,191	4,359	3,769
Operating Income	2,950	3,411	2,939	2,722	2,178
Interest Expense	-55.08	-38.49	-31.25	-28.73	-28.28
Interest & Investment Income	83.52	61.74	60.69	39.82	10.03
Earnings From Equity Investments	-0.33	0.15	0.07	0.18	-1.51
Currency Exchange Gain (Loss)	-573.9	-1,082	-706.57	-138.16	118.52
EBT Excluding Unusual Items	2,404	2,352	2,262	2,595	2,277
Pretax Income	2,404	2,352	2,262	2,595	2,277
Income Tax Expense	492.21	339.63	269.06	354.63	336.02
Earnings From Continuing Operations	1,912	2,013	1,993	2,240	1,941
Minority Interest in Earnings	0.02	-0.07	0.05	1.49	5.97
Net Income	1,912	2,012	1,993	2,242	1,947
Net Income to Common	1,912	2,012	1,993	2,242	1,947
Net Income Growth	-4.99%	0.99%	-11.10%	15.14%	39.79%
Shares Outstanding (Basic)	872	872	872	872	872
Shares Outstanding (Diluted)	872	872	872	872	872
EPS (Basic)	2.19	2.31	2.29	2.57	2.23
EPS (Diluted)	2.19	2.31	2.29	2.57	2.23
EPS Growth	-4.99%	0.99%	-11.10%	15.14%	39.79%
Free Cash Flow	2,107	2,154	1,652	1,692	2,575
Free Cash Flow Per Share	2.42	2.47	1.90	1.94	2.95
Dividend Per Share	1.600	1.600	1.600	1.600	1.380
Dividend Growth	-	-	-	15.94%	53.33%
Gross Margin	52.35%	50.67%	45.37%	45.02%	41.97%
Operating Margin	20.78%	22.17%	18.70%	17.30%	15.37%
Profit Margin	13.47%	13.08%	12.68%	14.25%	13.74%
Free Cash Flow Margin	14.84%	14.00%	10.51%	10.76%	18.17%
EBITDA	3,154	3,614	3,146	2,917	2,378
EBITDA Margin	22.22%	23.49%	20.02%	18.55%	16.78%
D&A For EBITDA	203.96	202.84	207.49	195.24	200.2
EBIT	2,950	3,411	2,939	2,722	2,178
EBIT Margin	20.78%	22.17%	18.70%	17.30%	15.37%
Effective Tax Rate	20.47%	14.44%	11.90%	13.67%	14.76%
Revenue as Reported	14,278	15,447	15,776	15,767	14,301
Advertising Expenses	1,255	1,232	1,323	1,266	1,052

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.